(4-fluorotetrahydro-2H-pyran-4-yl)MethanaMine
≥95%
- Product Code: 36880
CAS:
1228875-13-5
| Molecular Weight: | 133.16 g./mol | Molecular Formula: | C₆H₁₂FNO |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | 184.0±25.0℃(Predicted) | |
| Density: | 1.06±0.1 g/cm3(Predicted) | Storage Condition: | 2-8℃, dry and avoid light |
Product Description:
This chemical is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as a key intermediate in the creation of compounds targeting neurological disorders, such as depression and anxiety, due to its structural properties that can interact with specific receptors in the brain. Additionally, it is explored for its potential in developing medications for chronic pain management and inflammation. Its unique fluorinated pyran structure also makes it valuable in medicinal chemistry for enhancing the bioavailability and metabolic stability of therapeutic agents.
Product Specification:
| Test | Specification |
|---|---|
| APPEARANCE | Colorless to light yellow Liquid |
| PURITY | 94.5-100 |
| Infrared spectrum | Conforms to Structure |
| NMR | Conforms to Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿6,200.00 |
+
-
|
| 0.250 | 10-20 days | ฿12,800.00 |
+
-
|
| 1.000 | 10-20 days | ฿48,300.00 |
+
-
|
(4-fluorotetrahydro-2H-pyran-4-yl)MethanaMine
This chemical is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. It serves as a key intermediate in the creation of compounds targeting neurological disorders, such as depression and anxiety, due to its structural properties that can interact with specific receptors in the brain. Additionally, it is explored for its potential in developing medications for chronic pain management and inflammation. Its unique fluorinated pyran structure also makes it valuable in medicinal chemistry for enhancing the bioavailability and metabolic stability of therapeutic agents.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :